FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Fussell Stephen R 		2. Issuer Name and Ticker or Trading Symbol

ABBOTT LABORATORIES [ ABT ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Executive Vice President
(Last)          (First)          (Middle)

100 ABBOTT PARK ROAD 		3. Date of Earliest Transaction (MM/DD/YYYY)

8/16/2017
(Street)

ABBOTT PARK, IL 60064-6400
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common shares without par value   8/16/2017     M    39350   A $26.6973   221488   D    
Common shares without par value   8/16/2017     M    38700   A $26.015   260188   D    
Common shares without par value   8/16/2017     M    28700   A $26.1879   288888   D    
Common shares without par value   8/16/2017     M    45800   A $22.3919   334688   D    
Common shares without par value   8/16/2017     M    44000   A $27.0336   378688   D    
Common shares without par value   8/16/2017     S    196550   D $49.50   182138   D    
Common shares without par value                  1570   (1) I   Profit Sharing Trust  
Common shares without par value                  53   (2) I   By Spouse  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy)   (3) $26.6973   8/16/2017     M         39350    2/15/2011   2/14/2018   Common shares   39350   $0   0   D    
Option (right to buy)   (3) $26.0150   8/16/2017     M         38700    2/20/2012   2/19/2019   Common shares   38700   $0   0   D    
Option (right to buy)   (4) $26.1879   8/16/2017     M         28700    2/19/2013   2/18/2020   Common shares   28700   $0   0   D    
Option (right to buy)   (4) $22.3919   8/16/2017     M         45800    2/18/2014   2/17/2021   Common shares   45800   $0   0   D    
Option (right to buy)   (4) $27.0336   8/16/2017     M         44000    2/17/2015   2/16/2022   Common shares   44000   $0   0   D    

Explanation of Responses:
(1)  Balance in the Abbott Laboratories Stock Retirement Trust as of August 16, 2017.
(2)  The reporting person disclaims beneficial ownership of all securities held by his spouse.
(3)  Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
(4)  Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Fussell Stephen R
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-6400

Executive Vice President

Signatures
John A. Berry, by power of attorney for Stephen R. Fussell 8/18/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Abbott Laboratories Charts.